comparemela.com

Latest Breaking News On - John kraus - Page 4 : comparemela.com

FDA clears first digital treatment for depression, but experts caution that research is still early - WSVN 7News | Miami News, Weather, Sports

(CNN) The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.Rejoyn, made by<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/fda-clears-first-digital-treatment-for-depression-but-experts-caution-that-research-is-still-early/">Read More</a>

United statesJohn torousBrian iacovielloJohn krausDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical center

FDA clears first digital treatment for depression, but experts caution research is still early

Rejoyn is an app intended for use alongside antidepressant medications for people with major depressive disorder.

United statesBrian iacovielloJohn krausJohn torousDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical centerOb marketComputer science

Former Mayville Mayor Rob Boelk wins back office

Former Mayville Mayor Rob Boelk will be returning to office after defeating one-term Mayor John Guinn in Tuesday s election.

Kevin burnettJeff caineKaren gibbsJodi schultzBarbara brakerJoseph tillmannMarge jorgensenJim kylerHeather scholzGary devriesBrittany borchardtRebecca droessler merschStephen chenJody stegerRyan rostadAlyssa gahlman

FDA clears first digital treatment for depression, but experts caution that research is still early

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

United statesBrian iacovielloJohn torousJohn krausDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical center

FDA clears first digital treatment for depression, but experts caution that research is still early

(CNN) — The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

United statesJohn torousJohn krausBrian iacovielloCable news network incDiscovery companyWarner brosDrug administrationOtsuka pharmaceuticalClick therapeuticsEmotional faces memory taskDigital psychiatryBeth israel deaconess medical centerNews network

vimarsana © 2020. All Rights Reserved.